Masimo (MASI) Equity Ratio (2010 - 2026)
Masimo's quarterly Equity Ratio came in at 0.48 in Q2 2026, up 16.36% year-on-year from 0.41 in Q2 2025, and up 13.13% quarter-over-quarter from 0.42 in Q1 2026.
Masimo has reported Equity Ratio for 17 years, with the latest figure at 0.48 in Q2 2026.
- For the quarter ending Q2 2026, Equity Ratio rose 16.36% year-over-year to 0.48; the trailing twelve-month figure through Apr 2026 stood at 0.48 (up 16.36% YoY), and the FY2026 full-year result was 0.42, up 5.96% from the prior year.
- Equity Ratio for Q2 2026 stood at 0.48, up from 0.42 in the prior quarter.
- The five-year high for Equity Ratio was 0.83 in Q2 2022, with the low at 0.4 in Q4 2024.
- Average Equity Ratio over 5 years is 0.48, with a median of 0.43 recorded in 2023.
- Year-over-year, Equity Ratio tumbled 50.91% in 2022 and gained 16.36% in 2026.
- Tracing MASI's Equity Ratio over 5 years: stood at 0.42 in 2022, then advanced by 7.6% to 0.45 in 2023, then dropped by 10.72% to 0.4 in 2024, then rose by 11.25% to 0.45 in 2025, then rose by 7.76% to 0.48 in 2026.
- The last three Equity Ratio figures came in at 0.48 (Q2 2026), 0.42 (Q1 2026), and 0.45 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 0.48 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 0.48 |
| Jan 3, 2026 | 0.42 |
| Sep 27, 2025 | 0.45 |
| Jun 28, 2025 | 0.43 |
| Mar 29, 2025 | 0.41 |
| Dec 28, 2024 | 0.40 |
| Sep 28, 2024 | 0.47 |
| Jun 29, 2024 | 0.47 |
| Mar 30, 2024 | 0.46 |
| Dec 30, 2023 | 0.45 |
| Sep 30, 2023 | 0.43 |
| Jul 1, 2023 | 0.43 |
| Apr 1, 2023 | 0.43 |
| Dec 31, 2022 | 0.42 |
| Oct 1, 2022 | 0.41 |
| Jul 2, 2022 | 0.41 |
| Apr 2, 2022 | 0.83 |
| Jan 1, 2022 | 0.82 |
| Oct 2, 2021 | 0.83 |
| Jul 3, 2021 | 0.83 |
| Apr 3, 2021 | 0.83 |
| Jan 2, 2021 | 0.82 |
| Sep 26, 2020 | 0.83 |
| Jun 27, 2020 | 0.82 |
| Mar 28, 2020 | 0.85 |
| Dec 28, 2019 | 0.84 |
| Sep 28, 2019 | 0.84 |
| Jun 29, 2019 | 0.85 |
| Mar 30, 2019 | 0.85 |
| Dec 29, 2018 | 0.84 |
| Sep 29, 2018 | 0.83 |
| Jun 30, 2018 | 0.82 |
| Mar 31, 2018 | 0.81 |
| Dec 30, 2017 | 0.80 |
| Sep 30, 2017 | 0.79 |
| Jul 1, 2017 | 0.79 |
| Apr 1, 2017 | 0.72 |
| Dec 31, 2016 | 0.71 |
| Oct 1, 2016 | 0.52 |
| Jul 2, 2016 | 0.49 |
| Apr 2, 2016 | 0.43 |
| Jan 2, 2016 | 0.48 |
| Oct 3, 2015 | 0.46 |
| Jul 4, 2015 | 0.49 |
| Apr 4, 2015 | 0.56 |
| Jan 3, 2015 | 0.54 |
| Sep 27, 2014 | 0.53 |
| Jun 28, 2014 | 0.64 |
| Mar 29, 2014 | 0.77 |
| Dec 28, 2013 | 0.74 |
| Sep 28, 2013 | 0.73 |
| Jun 29, 2013 | 0.74 |
| Mar 30, 2013 | 0.72 |
| Dec 29, 2012 | 0.74 |
| Sep 29, 2012 | 0.77 |
| Mar 31, 2012 | 0.73 |
| Dec 31, 2011 | 0.76 |
| Oct 1, 2011 | 0.79 |
| Jul 2, 2011 | 0.79 |
| Apr 2, 2011 | 0.77 |
| Jan 1, 2011 | 0.74 |
| Oct 2, 2010 | 0.75 |
| Jul 3, 2010 | 0.75 |
| Jan 2, 2010 | 0.81 |